Expression of cell-cycle regulatory proteins and their prognostic value in superficial low-grade urothelial cell carcinoma of the bladder

被引:44
作者
Santos, LL
Amaro, T
Pereira, SA
Lameiras, CR
Lopes, P
Bento, MJ
Oliveira, J
Criado, B
Lopes, CS
机构
[1] Inst Portugues Oncol Francisco Gentil, Dept Surg Oncol, P-4200 Oporto, Portugal
[2] Inst Portugues Oncol Francisco Gentil, Mol Oncol Unit, P-4200 Oporto, Portugal
[3] Inst Portugues Oncol Francisco Gentil, Dept Pathol, P-4200 Oporto, Portugal
[4] Inst Portugues Oncol Francisco Gentil, Epidemiol Unit, P-4200 Oporto, Portugal
[5] Inst Portugues Oncol Francisco Gentil, Dept Urol, P-4200 Oporto, Portugal
[6] High Sch Hlth Vale Do Ave, Famalicao, Portugal
来源
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY | 2003年 / 29卷 / 01期
关键词
bladder cancer; prognostic factor; cell-cycle proteins; Ki-67;
D O I
10.1053/ejso.2002.1371
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: Cell-cycle regulatory proteins are important indicators in determining progression trough the cell-cycle and progression to invasive cancer in patients presenting with superficial bladder cancer. We performed an immunohistochemical study in order to evaluate the prognostic value of the expression of p 16, p27, pRb, p53 and Ki-67 in superficial grade I and II papillary urothelial cell carcinoma of the bladder. Methods: p16, p27, p53, pRb and Ki-67 immunoexpression was studied in 14 pTa, 35 pTla and 7 pTlb bladder tumours at presentation and at recurrence of their tumours. The recurrence-free survival and the progression-free survival were analysed according to these regulatory cell-cycle proteins expression. Results: For survival in univariate analysis a high Ki-67 labelling index was a poor prognostic factor for recurrence free and progression-free survival (P = 0.0014 and P = 0.012, respectively). Ki-67 labelling index was also an independent recurrence-free survival prognostic factor (P = 0.0005). The p 16, p27, p53 and pRb immunoreactivity was not significantly associated with recurrence or progression rate in this group of bladder carcinomas. Conclusions: These data suggest that the Ki-67 labelling index can be a reliable marker in predicting recurrence and/or progression in superficial low-grade bladder carcinomas and may be relevant in planning adjuvant therapy. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:74 / 80
页数:7
相关论文
共 61 条
  • [1] [Anonymous], 1997, AJCC CANC STAG MAN
  • [2] [Anonymous], INT CLASSIFICATION T
  • [3] Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer
    Benedict, WF
    Lerner, SP
    Zhou, J
    Shen, XH
    Tokunaga, H
    Czerniak, B
    [J]. ONCOGENE, 1999, 18 (05) : 1197 - 1203
  • [4] CAIRNS P, 1994, CANCER RES, V54, P1422
  • [5] CAIRNS P, 1993, ONCOGENE, V8, P1083
  • [6] CAIRNS P, 1991, ONCOGENE, V6, P2305
  • [7] CAIRNS P, 1993, CANCER RES, V53, P1230
  • [8] New insights into the tumor suppression function of P27Kip1
    Clurman, BE
    Porter, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) : 15158 - 15160
  • [9] CLURMAN BE, 1998, GENETIC BASIS HUMAN, P175
  • [10] COHEN SM, 1992, UROL CLIN N AM, V19, P421